Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C5orf28 Inhibitors

The inhibitors of C5orf28 function through a variety of mechanisms to decrease the protein's activity, primarily by acting on the signaling pathways that are crucial for its function. For instance, the inhibition of the mTOR signaling cascade, which is essential for a multitude of cellular processes including those that C5orf28 is involved in, results in a decrease in the protein's activity. By targeting this pathway, the inhibitors are able to exert an indirect effect on C5orf28, leading to its decreased functionality. Similarly, the PI3K/Akt pathway, a vital signaling mechanism that influences cellular survival and growth, is another target of these inhibitors. By disrupting this pathway, the inhibitors can effectively reduce the activity of C5orf28, given its involvement in the same cellular processes.

Moreover, the inhibitors act on the MEK/ERK and p38 MAPK pathways, both of which are implicated in the regulation of cell proliferation, differentiation, and stress responses, processes that C5orf28 is associated with. By preventing the activation of these pathways, the inhibitors indirectly lead to a reduction in C5orf28 function. The JNK signaling pathway, which is linked to inflammatory responses and apoptosis, is also a target for some inhibitors. The disruption of this pathway signifies a decrease in C5orf28 activity due to its association with this signaling cascade.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that indirectly inhibits the activity of C5orf28 by altering downstream signaling pathways that C5orf28 is involved in.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that disrupts the PI3K/Akt pathway, which is integral to the processes C5orf28 is involved in, leading to its functional inhibition.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

This compound is a potent PI3K inhibitor and affects the Akt signaling cascade, which C5orf28 is a part of, thus inhibiting its activity.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Acts by specifically inhibiting the Akt/mTOR pathway, which C5orf28 plays a role in, thereby decreasing the functional activity of C5orf28.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A MEK inhibitor that disrupts ERK pathway signaling. C5orf28 activity is contingent on this pathway, and its inhibition reduces C5orf28 function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, affecting the MAPK pathway where C5orf28 is involved, leading to a decrease in C5orf28 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor that disrupts the JNK signaling pathway. As C5orf28 is part of this pathway, its function is indirectly inhibited by this compound.

BIX 02189

1094614-85-3sc-364436
sc-364436A
5 mg
10 mg
$224.00
$386.00
5
(1)

A specific inhibitor of MEK5, which leads to the inhibition of the ERK5 pathway, a pathway that C5orf28 is dependent on for full activity.

SL-327

305350-87-2sc-200685
sc-200685A
1 mg
10 mg
$107.00
$332.00
7
(0)

Specifically inhibits MEK1/2, thereby inhibiting the ERK signaling pathway and indirectly reducing the functional activity of C5orf28.

ZSTK 474

475110-96-4sc-475495
5 mg
$75.00
(0)

A PI3K inhibitor that, by inhibiting PI3K, affects the Akt pathway. Since C5orf28 operates within this pathway, its activity is indirectly decreased.